Cargando…

Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma

Background Hepatocellular Carcinoma (HCC) is a severe complication of cirrhosis and the incidence of HCC has been increasing in the United States (US). We aim to describe the trends, characteristics, and outcomes of hospitalizations due to HCC across the last decade. Methods We derived a study cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullangi, Sanjana, Keesari, Praneeth R, Zaher, Anas, Pulakurthi, Yashwitha Sai, Adusei Poku, Frank, Rajeev, Arathi, Vidiyala, Prasanna Lakshmi, Guntupalli, Asha Latha, Desai, Maheshkumar, Ohemeng-Dapaah, Jessica, Asare, Yaw, Patel, Achint A, Lekkala, Manidhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723719/
https://www.ncbi.nlm.nih.gov/pubmed/35003948
http://dx.doi.org/10.7759/cureus.20089
_version_ 1784625778464391168
author Mullangi, Sanjana
Keesari, Praneeth R
Zaher, Anas
Pulakurthi, Yashwitha Sai
Adusei Poku, Frank
Rajeev, Arathi
Vidiyala, Prasanna Lakshmi
Guntupalli, Asha Latha
Desai, Maheshkumar
Ohemeng-Dapaah, Jessica
Asare, Yaw
Patel, Achint A
Lekkala, Manidhar
author_facet Mullangi, Sanjana
Keesari, Praneeth R
Zaher, Anas
Pulakurthi, Yashwitha Sai
Adusei Poku, Frank
Rajeev, Arathi
Vidiyala, Prasanna Lakshmi
Guntupalli, Asha Latha
Desai, Maheshkumar
Ohemeng-Dapaah, Jessica
Asare, Yaw
Patel, Achint A
Lekkala, Manidhar
author_sort Mullangi, Sanjana
collection PubMed
description Background Hepatocellular Carcinoma (HCC) is a severe complication of cirrhosis and the incidence of HCC has been increasing in the United States (US). We aim to describe the trends, characteristics, and outcomes of hospitalizations due to HCC across the last decade. Methods We derived a study cohort from the Nationwide Inpatient Sample (NIS) for the years 2008-2017. Adult hospitalizations due to HCC were identified using the International Classification of Diseases (9th/10th Editions) Clinical Modification diagnosis codes (ICD-9-CM/ICD-10-CM). Comorbidities were also identified by ICD-9/10-CM codes and Elixhauser Comorbidity Software (Agency for Healthcare Research and Quality, Rockville, Maryland, US). Our primary outcomes were in-hospital mortality and discharge to the facility. We then utilized the Cochran-Armitage trend test and multivariable survey logistic regression models to analyze the trends, outcomes, and predictors. Results A total of 155,436 adult hospitalizations occurred due to HCC from 2008-2017. The number of hospitalizations with HCC decreased from 16,754 in 2008 to 14,715 in 2017. Additionally, trends of in-hospital mortality declined over the study period but discharge to facilities remained stable. Furthermore, in multivariable regression analysis, predictors of increased mortality in HCC patients were advanced age (OR 1.1; 95%CI 1.0-1.2; p< 0.0001), African American (OR 1.3; 95%CI 1.1-1.4;p< 0.001), Rural/ non-teaching hospitals (OR 2.7; 95%CI 2.4-3.3; p< 0.001), uninsured (OR 1.9; CI 1.6-2.2; p< 0.0001) and complications like septicemia and pneumonia as well as comorbidities such as hypertension, diabetes mellitus, and renal failure. We observed similar trends in discharge to facilities. Conclusions In this nationally representative study, we observed a decrease in hospitalizations of patients with HCC along with in-hospital mortality; however, discharge to facilities remained stable over the last decade. We also identified multiple predictors significantly associated with increased mortality, some of which are potentially modifiable and can be points of interest for future studies.
format Online
Article
Text
id pubmed-8723719
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87237192022-01-06 Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma Mullangi, Sanjana Keesari, Praneeth R Zaher, Anas Pulakurthi, Yashwitha Sai Adusei Poku, Frank Rajeev, Arathi Vidiyala, Prasanna Lakshmi Guntupalli, Asha Latha Desai, Maheshkumar Ohemeng-Dapaah, Jessica Asare, Yaw Patel, Achint A Lekkala, Manidhar Cureus Internal Medicine Background Hepatocellular Carcinoma (HCC) is a severe complication of cirrhosis and the incidence of HCC has been increasing in the United States (US). We aim to describe the trends, characteristics, and outcomes of hospitalizations due to HCC across the last decade. Methods We derived a study cohort from the Nationwide Inpatient Sample (NIS) for the years 2008-2017. Adult hospitalizations due to HCC were identified using the International Classification of Diseases (9th/10th Editions) Clinical Modification diagnosis codes (ICD-9-CM/ICD-10-CM). Comorbidities were also identified by ICD-9/10-CM codes and Elixhauser Comorbidity Software (Agency for Healthcare Research and Quality, Rockville, Maryland, US). Our primary outcomes were in-hospital mortality and discharge to the facility. We then utilized the Cochran-Armitage trend test and multivariable survey logistic regression models to analyze the trends, outcomes, and predictors. Results A total of 155,436 adult hospitalizations occurred due to HCC from 2008-2017. The number of hospitalizations with HCC decreased from 16,754 in 2008 to 14,715 in 2017. Additionally, trends of in-hospital mortality declined over the study period but discharge to facilities remained stable. Furthermore, in multivariable regression analysis, predictors of increased mortality in HCC patients were advanced age (OR 1.1; 95%CI 1.0-1.2; p< 0.0001), African American (OR 1.3; 95%CI 1.1-1.4;p< 0.001), Rural/ non-teaching hospitals (OR 2.7; 95%CI 2.4-3.3; p< 0.001), uninsured (OR 1.9; CI 1.6-2.2; p< 0.0001) and complications like septicemia and pneumonia as well as comorbidities such as hypertension, diabetes mellitus, and renal failure. We observed similar trends in discharge to facilities. Conclusions In this nationally representative study, we observed a decrease in hospitalizations of patients with HCC along with in-hospital mortality; however, discharge to facilities remained stable over the last decade. We also identified multiple predictors significantly associated with increased mortality, some of which are potentially modifiable and can be points of interest for future studies. Cureus 2021-12-01 /pmc/articles/PMC8723719/ /pubmed/35003948 http://dx.doi.org/10.7759/cureus.20089 Text en Copyright © 2021, Mullangi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Mullangi, Sanjana
Keesari, Praneeth R
Zaher, Anas
Pulakurthi, Yashwitha Sai
Adusei Poku, Frank
Rajeev, Arathi
Vidiyala, Prasanna Lakshmi
Guntupalli, Asha Latha
Desai, Maheshkumar
Ohemeng-Dapaah, Jessica
Asare, Yaw
Patel, Achint A
Lekkala, Manidhar
Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
title Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
title_full Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
title_fullStr Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
title_full_unstemmed Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
title_short Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma
title_sort epidemiology and outcomes of hospitalizations due to hepatocellular carcinoma
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723719/
https://www.ncbi.nlm.nih.gov/pubmed/35003948
http://dx.doi.org/10.7759/cureus.20089
work_keys_str_mv AT mullangisanjana epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT keesaripraneethr epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT zaheranas epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT pulakurthiyashwithasai epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT aduseipokufrank epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT rajeevarathi epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT vidiyalaprasannalakshmi epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT guntupalliashalatha epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT desaimaheshkumar epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT ohemengdapaahjessica epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT asareyaw epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT patelachinta epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma
AT lekkalamanidhar epidemiologyandoutcomesofhospitalizationsduetohepatocellularcarcinoma